Slow Bull
The market, slowly. FRIDAY, 25 SEPTEMBER 2026

Atossa Therapeutics, Inc.

company in Seattle, United States

ATOS Nasdaq SEC CIK 1488039
Follow Atossa Therapeutics Weekly email: filings, results, news

Financials

Reported figures only · latest: Q2 2026 USD · US GAAP
Net income −$8.5M −0.8% vs same quarter last year
EPS, diluted −$0.95 +3.1% vs same quarter last year
Operating cash flow −$9.6M −32.9% vs same quarter last year
Operating income −$8.7M +3.8% vs same quarter last year
Net income by quarter
−$7.2M
−$6.3M
−$6.7M
−$8.4M
−$8.7M
−$10.9M
−$9.6M
−$8.5M
Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$40M−$30M−$20M−$10M$0$10MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25-−$34.8M
FY24-−$25.5M
FY23-−$30.1M
FY22-−$27M
FY21-−$20.6M
FY20-−$17.8M
FY19-−$17.2M
FY18-−$11.4M
FY17-−$8.1M
FY16-−$6.4M
FY15$1.8K−$15.8M
FY14$40.1K−$14.7M
FY13$632.6K−$10.8M
FY12$481.8K−$5.1M
FY11$1.5K−$3.4M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−1000000%−750000%−500000%−250000%0%250000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY25---
FY24---
FY23---
FY22---
FY21---
FY20---
FY19---
FY18---
FY17---
FY16---
FY15−7431.9%−725746.2%−896491.6%
FY14100%−30323%−36518.8%
FY1321.7%−1704.9%−1704.9%
FY1286.4%−1052%−1054.3%
FY11−6379.3%−228612.7%−229484.5%
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$29.8M
FY24−$21M
FY23−$21M
FY22−$20.8M
FY21−$16.5M
FY20−$11.6M
FY19−$9.1M
FY18−$9.1M
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
FY11-
Returned to shareholdersDividends paid and shares bought back
$0$500K$1M$1.5MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearBuybacks
FY25-
FY24$0
FY23$1.5M
FY22$0
FY21-
FY20-
FY19-
FY18-
FY17-
FY16-
FY15-
FY14-
FY13-
FY12-
FY11-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Atossa Therapeutics
  • Healthcare median
−1000000%−750000%−500000%−250000%0%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearAtossa TherapeuticsHealthcare median
FY25-−40.6%
FY24-−60.7%
FY23-−97.1%
FY22-−128.5%
FY21-−129.2%
FY20-−136.5%
FY19-−133.7%
FY18-−173.4%
FY17-−176.7%
FY16-−164.8%
FY15−896491.6%−183.4%
FY14−36518.8%−133%
FY13−1704.9%−88.5%
FY12−1054.3%−87.4%
FY11−229484.5%−76.3%

News

No stories filed under Atossa Therapeutics yet - coverage appears here as the news feed clusters it.